Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 9753
TargetBeta-2 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485867(US10947196, Compound 03-3)
Affinity DataEC50: <10nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485867(US10947196, Compound 03-3)
Affinity DataEC50:  55nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485866(US10947196, Compound 03-2)
Affinity DataEC50:  550nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485956(US10947196, Compound 03-4)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485956(US10947196, Compound 03-4)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485866(US10947196, Compound 03-2)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485865(US10947196, Compound 03-1)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Human)
Curasen Therapeutics

US Patent
LigandPNGBDBM485865(US10947196, Compound 03-1)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent